Abstract
Interactions between anti-epileptic drugs are well known. Thus, interactions between phenobarbitone and phenytoin have been reported by Cucinell et al. (1965), Kristensen et al. (1969), Kutt et al. (1969) and Morselli et al. (1971), between sulthiame and phenytoin by Hansen et al. (1968) and Olesen and Jensen (1969), and between carbamazepine and phenytoin by Hansen et al. (1971 b).
Presented in part at the X International Congress of Neurology, Barcelona, 1973. Excerpta Med., ICS 296, 263 (1973).
Reprint requests.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Choi, Y., Trasher, K., Werk, E. E., Sholiton, L. J., Olinger, C.: Effect of diphenylhydantoin on Cortisol kinetics in humans. J. Pharmacol, exp. Ther. 176, 27 (1971).
Christiansen, J., Dam, M.: Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy. Acta neurol. scand. 49, 543 (1973).
Conney, A. H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317 (1967).
Cucinell, S. A., Conney, A. H., Sansur, M., Burns, J. J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol®) and diphenylhydantoin (Dilantin®). Clin. Pharmacol. Ther. 6, 420 (1965).
Davies, J. E., Edmundson, W. F., Carter, C. H., Barquet, A.: Effect of anticonvulsant drugs on dicophane (D.D.T.) residues in man. Lancet 1969 II, 7.
Hansen, J. M., Kristensen, M., Skovsted, L.: Sulthiame (Ospolot®) as inhibitor of diphenylhydantoin metabolism. Epilepsia 9, 17 (1968).
Hansen, J. M., Siersbaek-Nielsen, K., Kristensen, M., Skovsted, L., Christensen, L. K.: Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta med. scand. 189, 15 (1971 a).
Hansen, J. M., Siersbaek-Nielsen, K, Skovsted, L.: Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin. Pharmacol. Ther. 12, 539 (1971 b).
Haque, N., Trasher, K., Werk, E. E., Knowles, H. C., Sholiton, L. J.: Studies of dexamethasone metabolism in man. Effect of diphenylhydantoin. J. clin. Endocrinol. 34, 44 (1972).
Johannessen, S. I., Strandjord, R. E.: Concentration of carbamazepine (Tegretol®) in serum and in cerebrospinal fluid in patients with epilepsy. Epilepsia 14, 373 (1973).
Kristensen, M., Hansen, J. M., Skovsted, L.: The influence of phenobarbital on the half-life of diphenylhydantoin in man. Acta med. scand. 185, 347 (1969).
Kutt, H., Haynes, J., Verebely, K, McDowell, F.: The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes. Neurology (Minneap.) 19, 611 (1969).
Meikle, A. W., Jubiz, W., Matsakura, S., West, C. D., Tyler, F. H.: Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. J. clin. Endocrinol. 29, 1553 (1969).
Morselli, P. L., Rizzo, M., Garattini, S.: Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann. N. Y. Acad. Sci. 179, 88 (1971).
Olesen, O. V., Jensen, O. N.: Drug-interaction between sulthiame (Ospolot®) and phenytoin in the treatment of epilepsy. Dan. med. Bull. 16, 154 (1969).
Solomon, H. M., Reich, S., Spirt, N., Abrams, W. B.: Interactions between digitoxin and other drugs in vitro and in vivo. Ann. N.Y. Acad. Sci. 179, 362 (1971).
Werk, E. E., Trasher, K, Sholiton, L. J., Olinger, C., Choi, Y.: Cortisol production in epileptic patients treated with diphenylhydantoin. Clin. Pharmacol. Ther. 12, 698 (1971).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin-Heidelberg
About this paper
Cite this paper
Johannessen, S.I., Strandjord, R.E. (1975). The Influence of Phenobarbitone and Phenytoin on Carbamazepine Serum Levels. In: Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H., Sherwin, A.L. (eds) Clinical Pharmacology of Anti-Epileptic Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85921-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-85921-2_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85923-6
Online ISBN: 978-3-642-85921-2
eBook Packages: Springer Book Archive